Sovaldi Tablets
- All
- News
-
How an $84,000 Drug Got Its Price: 'Let's Hold our Position... Whatever the Headlines'
Gilead Sciences executives were acutely aware in 2013 that their plan to charge an exorbitantly high price for a powerful new hepatitis C drug would spark public outrage, but they pursued the profit-driven strategy anyway, according to a Senate Finance Committee investigation report released Tuesday.
-
Mylan Launches Sovaldi Tablets in India
Sovaldi is indicated for the treatment of chronic hepatitis-C infection as a component of a combination antiviral treatment.
-
How an $84,000 Drug Got Its Price: 'Let's Hold our Position... Whatever the Headlines'
Gilead Sciences executives were acutely aware in 2013 that their plan to charge an exorbitantly high price for a powerful new hepatitis C drug would spark public outrage, but they pursued the profit-driven strategy anyway, according to a Senate Finance Committee investigation report released Tuesday.
-
Mylan Launches Sovaldi Tablets in India
Sovaldi is indicated for the treatment of chronic hepatitis-C infection as a component of a combination antiviral treatment.
